Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers

Cancer Science

Volumn 103, Issue 6, 2012, Pages 1000-1009

  Xu, Yali ^a   Liu, Xiaoxia ^a   Guo, Fenghua ^b   Ning, Yanxia ^a   Zhi, Xiuling ^a   Wang, Xinhong ^a   Chen, Sifeng ^a   Yin, Lianhua ^a   Li, Xiaobo ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN D1; ESTROGEN SULFOTRANSFERASE; HYDROGEN PEROXIDE; MYC PROTEIN; PAPSS 1 PROTEIN; PAPSS 2 PROTEIN; PROTEIN BAX; PROTEIN BCL 2; SULT1E1 PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST; BREAST CANCER; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM; ENDOMETRIUM CANCER; ESTROGEN RESPONSIVE ELEMENT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SULFATION; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGENS; FEMALE; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIENZYME COMPLEXES; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; SULFATE ADENYLYLTRANSFERASE; SULFOTRANSFERASES; TISSUE ARRAY ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84861657564     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02258.x     Document Type: Article

References (33)

1. Hu ZZ, Kagan BL, Ariazi EA et al. Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells. PLoS ONE 2011; 6: e20410.
2. Filigheddu N, Sampietro S, Chianale F et al. Diacylglycerol kinase alpha mediates 17-beta-estradiol-induced proliferation, motility, and anchorage-independent growth of Hec-1A endometrial cancer cell line through the G protein-coupled estrogen receptor GPR30. Cell Signal 2011; 23: 1988-96.
3. Foster PA, Purohit A. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers. J Endocrinol 2012; 212: 99-110.
4. Falany JL, Macrina N, Falany CN. Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation. Breast Cancer Res Treat 2002; 74: 167-76.
5. Thomas C, Gustafsson JA. The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 2011; 11: 597-608.
6. Hui Y, Yasuda T, Yasuda S et al. Inhibitory effects of nitrative stress on the sulfation of 17beta-estradiol and 4-methoxyestradiol by human MCF 10A mammary epithelial cells. Biol Pharm Bull 2011; 33: 1633-7.
7. Coughtrie MW. Sulfation through the looking glass-recent advances in sulfotransferase research for the curious. Pharmacogenomics J 2002; 2: 297-308.
8. Cole GB, Keum G, Liu J et al. Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc Natl Acad Sci USA 2010; 107: 6222-7.
9. Choi JY, Lee KM, Park SK et al. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1090-5.
10. Alnouti Y, Klaassen CD. Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice. J Pharmacol Exp Ther 2008; 324: 612-21.
11. Venkatachalam KV. Human 3′-phosphoadenosine 5′-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency. IUBMB Life 2003; 55: 1-11.
12. Xu ZH, Otterness DM, Freimuth RR et al. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization. Biochem Biophys Res Commun 2000; 268: 437-44.
13. Stelzer C, Brimmer A, Hermanns P, Zabel B, Dietz UH. Expression profile of Papss2 (3′-phosphoadenosine 5′-phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo. Dev Dyn 2007; 236: 1313-8.
14. Hirata H, Hinoda Y, Okayama N et al. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 2008; 112: 1964-73.
15. Bloomer CW, Kenyon L, Hammond E et al. Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas. Am J Clin Oncol 2003; 26: S75-80.
16. Ren S, Hylemon P, Zhang ZP et al. Identification of a novel sulfonated oxysterol, 5-cholesten-3beta, 25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria. J Lipid Res 2006; 47: 1081-90.
17. Bai Q, Li X, Ning Y, Zhao F, Yin L. Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis. Lipids 2010; 45: 29-36.
18. Yeong P, Ning Y, Xu Y, Li X, Yin L. Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation. Biochim Biophys Acta 2010; 1801: 567-76.
19. Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 2010; 38: D792-9.
20. Yan LX, Wu QN, Zhang Y et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 2011; 13: R2.
21. Fujishita S, Inaba C, Tada S, Gemmei-Ide M, Kitano H, Saruwatari Y. Effect of zwitterionic polymers on wound healing. Biol Pharm Bull 2008; 31: 2309-15.
22. Falany JL, Falany CN. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 1996; 56: 1551-5.
23. Falany JL, Falany CN. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol Res 1997; 9: 589-96.
24. Geisler J, Sasano H, Chen S, Purohit A. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy? J Steroid Biochem Mol Biol 2011; 125: 39-45.
25. Stjernschantz E, Reinen J, Meinl W et al. Comparison of murine and human estrogen sulfotransferase inhibition in vitro and in silico - implications for differences in activity, subunit dimerization and substrate inhibition. Mol Cell Endocrinol 2010; 317: 127-40.
26. Xu Z, Wood TC, Adjei AA, Weinshilboum RM. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation. Drug Metab Dispos 2001; 29: 172-8.
27. Besset S, Vincourt JB, Amalric F, Girard JP. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells. FASEB J 2000; 14: 345-54.
28. Faiyaz ul Haque M, King LM, Krakow D et al. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse. Nat Genet 1998; 20: 157-62.
29. Kurima K, Warman ML, Krishnan S et al. A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc Natl Acad Sci USA 1998; 95: 8681-5.
30. Fu J, Weise AM, Falany JL et al. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Res Treat 2010; 120: 35-45.
31. Hynes NE, Stoelzle T. Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res 2009; 11: 210.
32. Musgrove EA, Sergio CM, Loi S et al. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS ONE 2008; 3: e2987.
33. Zwijsen RM, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides RJ. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997; 88: 405-15.